GlassScriptPhysician profile
Edward F Lundy
NPI 1144267386
$21,373.29
in general payments reported to CMS, 2019-2025
14 companies · $2,675 in 2025
The $2,675 reported for 2025 was more than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,892 · 2020: $3,319 · 2021: $2,438 · 2022: $3,813 · 2023: $3,672 · 2024: $1,564 · 2025: $2,675.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,911.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,910.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $12,366.03 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Aveir, Assurity |
| Abiomed | $3,162.37 | 2019-2025 | Impella |
| Medtronic Vascular, INC. | $1,328.36 | 2019-2020 | |
| Edwards Lifesciences Corporation | $1,316.13 | 2019-2025 | Mitris Resilia Mitral Valve |
| Medtronic, INC. | $1,174.80 | 2021-2025 | Symplicity G3, Penditure, Corevalve Evolut R |
| Atricure, INC. | $947.06 | 2020-2025 | Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System |
| Baxter Healthcare | $648.09 | 2021-2025 | Floseal, Coseal |
| Merck Sharp & Dohme LLC | $149.24 | 2023-2024 | Verquvo, Keytruda |
| Kestra Medical Technology Services, INC. | $148.32 | 2022 | |
| Angiodynamics, INC. | $38.72 | 2019-2025 | Angiovac |
| Artivion, INC. | $35.17 | 2025 | Amds-Ascyrus Medical |
| Biomerieux INC | $21.53 | 2019 | |
| Chiesi USA, INC. | $20.33 | 2023 | Cleviprex, Kengreal |
| Covidien LP | $17.14 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Lundy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.